Clinical trial
Effects of Valsartan on the Progression of Renal and Cardiovascular Disease - Kanagawa Valsartan Trial (KVT)
NCT00190580 is registered in ClinicalTrials.gov with KVT-Study Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Valsartan on the Progression of Renal and Cardiovascular Disease - Kanagawa Valsartan Trial (KVT)
- Lead sponsor
- KVT-Study Group
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2003
- Completion date
- April 30, 2008
- Enrollment
- 312 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease, hypertension